Although emerging evidence suggests that specific pathogens can colonise and exert pathological effects within the uterus, the mechanisms underlying maternal-fetal transmission and the downstream consequences for fetal health remain important directions for future investigation
We offer two separate compounded peptide formulations
Creatine is a compound made from three amino acids: arginine, glycine, and methionine

Potential benefits and considerations of DSIP therapy Potential benefits (based on available research) May support natural sleep architecture without pharmacological sedation Non-habit forming does not appear to carry dependency or tolerance risks comparable to benzodiazepines or opiates No reported morning grogginess in available studies Possible complementary effects on stress, pain, and immune regulation May support wellness goals related to longevity, cellular health, and metabolic support Considerations and limitations DSIP is investigational large-scale human clinical trials are limited Injectable forms require proper handling, reconstitution, and refrigeration Effects vary between individuals not all users report the same outcomes Cost may be higher than over-the-counter sleep aids Access requires a consultation with a qualified provider Safety profile and side effects The available research on DSIP suggests a generally favorable safety profile when used under professional supervision

Microglia: A potential therapeutic target for sepsis-associated encephalopathy and sepsis-associated chronic pain
Even though in some cases antagonists for bombesin-like peptide receptors enhance food ingestion, the contribution of endogenous bombesin-like peptides on the normal regulation of food intake is still unclear